BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26576611)

  • 1. [CRISPR-Cas9, a new chance for somatic gene therapy].
    Jordan B
    Med Sci (Paris); 2015 Nov; 31(11):1035-8. PubMed ID: 26576611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9 Technology in Translational Biomedicine.
    Leonova EI; Gainetdinov RR
    Cell Physiol Biochem; 2020 Apr; 54(3):354-370. PubMed ID: 32298553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic and diagnostic relevance of Crispr technology.
    El Ouar I; Djekoun A
    Biomed Pharmacother; 2021 Jun; 138():111487. PubMed ID: 33774312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in therapeutic CRISPR/Cas9 genome editing.
    Savić N; Schwank G
    Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1.
    Marsh S; Hanson B; Wood MJA; Varela MA; Roberts TC
    Mol Ther; 2020 Dec; 28(12):2527-2539. PubMed ID: 33171139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Genome Editing and its Potential Enhancement through CRISPR Guide RNA and Cas9 Modifications.
    Batzir NA; Tovin A; Hendel A
    Pediatr Endocrinol Rev; 2017 Jun; 14(4):353-363. PubMed ID: 28613045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR Mediated Genome Engineering and its Application in Industry.
    Kaboli S; Babazada H
    Curr Issues Mol Biol; 2018; 26():81-92. PubMed ID: 28879858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision genome editing in the CRISPR era.
    Salsman J; Dellaire G
    Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas9 in genome editing: Its function and medical applications.
    Khadempar S; Familghadakchi S; Motlagh RA; Farahani N; Dashtiahangar M; Rezaei H; Gheibi Hayat SM
    J Cell Physiol; 2019 May; 234(5):5751-5761. PubMed ID: 30362544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of CRISPR-Cas systems in neuroscience.
    Heidenreich M; Zhang F
    Nat Rev Neurosci; 2016 Jan; 17(1):36-44. PubMed ID: 26656253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas based gene editing: marking a new era in medical science.
    Prasad K; George A; Ravi NS; Mohankumar KM
    Mol Biol Rep; 2021 May; 48(5):4879-4895. PubMed ID: 34143395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Battling CRISPR-Cas9 off-target genome editing.
    Li D; Zhou H; Zeng X
    Cell Biol Toxicol; 2019 Oct; 35(5):403-406. PubMed ID: 31313008
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells.
    Hendel A; Bak RO; Clark JT; Kennedy AB; Ryan DE; Roy S; Steinfeld I; Lunstad BD; Kaiser RJ; Wilkens AB; Bacchetta R; Tsalenko A; Dellinger D; Bruhn L; Porteus MH
    Nat Biotechnol; 2015 Sep; 33(9):985-989. PubMed ID: 26121415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR, the disruptor.
    Ledford H
    Nature; 2015 Jun; 522(7554):20-4. PubMed ID: 26040877
    [No Abstract]   [Full Text] [Related]  

  • 15. CRISPR system for genome engineering: the application for autophagy study.
    Cui J; Chew SJL; Shi Y; Gong Z; Shen HM
    BMB Rep; 2017 May; 50(5):247-256. PubMed ID: 28288698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.
    El Refaey M; Xu L; Gao Y; Canan BD; Adesanya TMA; Warner SC; Akagi K; Symer DE; Mohler PJ; Ma J; Janssen PML; Han R
    Circ Res; 2017 Sep; 121(8):923-929. PubMed ID: 28790199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How specific is CRISPR/Cas9 really?
    O'Geen H; Yu AS; Segal DJ
    Curr Opin Chem Biol; 2015 Dec; 29():72-8. PubMed ID: 26517564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimizing off-target effects in CRISPR-Cas9 genome editing.
    Chen SJ
    Cell Biol Toxicol; 2019 Oct; 35(5):399-401. PubMed ID: 31317359
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential pitfalls of CRISPR/Cas9-mediated genome editing.
    Peng R; Lin G; Li J
    FEBS J; 2016 Apr; 283(7):1218-31. PubMed ID: 26535798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Based Technologies: Impact of RNA-Targeting Systems.
    Terns MP
    Mol Cell; 2018 Nov; 72(3):404-412. PubMed ID: 30388409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.